Gain critical insights from trusted sources
Our PTRS predictions are paired with contextual information about the therapy, such as its mechanism of action, abandoned indications and prediction drivers, including historical success of drugs with a similar molecular structure, inclusion/exclusion criteria and trial geography. This allows you to glean further insights about potential products, markets and competitors.
You can use insights provided by the IQVIA Asset Intelligence Tool as input for better clinical trial design, or to identify potential products for in-licensing. We pull from a plethora of trusted data sources and apply our advanced machine learning capabilities to quickly comb through vast amounts of relevant scientific and medical information to provide your team with the insights you need to make informed decisions.